(Q31936097)

5 July 2017

1 reference

title

Anti-anaerobic activity of antibacterial agents (English)

1 reference

5 July 2017

Bryskier A

1

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Expert Opinion on Investigational Drugs

5 July 2017

published in

1 reference

5 July 2017

volume

10

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

239-267

1 reference

A primer on anaerobic bacteria and anaerobic infections for the uninitiated

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Anaerobic infections in humans: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Anti-anaerobic antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Survey of anaerobic susceptibility patterns in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Survey of Bacteroides fragilis group susceptibility patterns in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Properties of novel beta-lactamase produced by Bacteroides fragilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Beta-lactam resistance in anaerobic bacteria: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

The in-vitro activity of L-627 against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In-vitro microbiological assessment of a new penem, Men 10700.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Novelties in the field of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Novelties in the field of anti-infectives in 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.239

10.1517/13543784.10.2.239

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference